Dr. Reddy's Laboratories Ltd Press Releases

RDY 
$53.44
*  
0.50
0.94%
Get RDY Alerts
*Delayed - data as of Jan. 26, 2015  -  Find a broker to begin trading RDY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    RDY After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Dr. Reddy's to Release Q3 FY15 Results on January 29, 2015
1/22/2015 10:31:00 AM - Business Wire
▼-1.40 % Price Change since this news event. The Volume Ratio is 1.38.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and Precision Oncology Targets
1/21/2015 6:05:00 AM - GlobeNewswire


Dr. Reddy’s Laboratories Closes the Acquisition of Habitrol® Brand from Novartis
12/19/2014 2:18:00 AM - Business Wire
▲6.28 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Dr. Reddy’s Announces the Launch of Valganciclovir Tablets, USP
12/16/2014 2:57:00 AM - Business Wire
▲2.43 % Price Change since this news event. The Volume Ratio is 1.59.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Dr. Reddy’s Announces the Launch of Docetaxel Injection USP
11/24/2014 2:29:00 AM - Business Wire


Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets
11/20/2014 9:15:00 AM - Business Wire


Dr. Reddy’s Q2 and H1 FY15 Financial Results
10/29/2014 6:41:00 AM - Business Wire
▲5.36 % Price Change since this news event. The Volume Ratio is 1.6.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day